CV Therapeutics Inc.

April 25, 2008 - CV Therapeutics reported the Committee for Medicinal Products for Human Use (CHMP) of the European ...

April 24, 2008

February 5, 2008 – CV Therapeutics Inc. and Medlogics Device Corp. entered into an agreement under which Medlogics has ...

February 04, 2008

April 25, 2007 — CV Therapeutics Inc. has announced that data from the MERLIN TIMI-36 study will be published in this ...

April 24, 2007

CV Therapeutics has announced it will file a new drug application to the FDA for its regadenoson agent in mid-2007 ...

December 04, 2006

CV Therapeutics Inc. says the MERLIN TIMI-36 study of ranolazine will proceed to the study close-out phase now that the ...

October 05, 2006

Related Content